By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Business of researching, developing and commercializing drugs for the treatment of patients with11.24M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States10M100.00%